Xi Wang

Dr. Xi Wang

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
BZBaoli Zhu
Baoli Zhu
SWSiyi Wang
Siyi Wang
XWXi Wang
Xi Wang
GXGuojin Xu
Guojin Xu
QLQiuying Liu
Qiuying Liu
BZBaoli Zhu
Baoli Zhu
The vaginal microbiota can be classified into five major community state types (CSTs) based on the bacterial content. However, the link between different CST subtypes and vaginal infection remains unclear. Here, we analyzed 2017 vaginal microbiota samples from women of a reproductive age with vaginal infections that were published in the last decade. We found that L. iners was the most dominant in 34.8% of the vaginal samples, followed by L. crispatus (21.2%). CST I was common in healthy individuals, whereas CST III and IV were associated with dysbiosis and infection. CST III-B, IV-A, IV-B, and IV-C0 were prevalent in patients with bacterial vaginosis (BV). Based on the relative abundance of bacteria at the (sub)genus level, a random forest classifier was developed to predict vaginal infections with an area under the curve of 0.83. We further identified four modules of co-occurring bacterial taxa: L. crispatus, Gardnerella, Prevotella, and Bacteroides. The functional prediction revealed that nucleotide biosynthesis pathways were upregulated in patients with human papilloma virus, and carbohydrate degradation pathways were downregulated in patients with BV. Overall, our study identified the bacterial signatures of healthy and infected vaginal microbiota, providing unique insights into the clinical diagnosis and health status prediction of women of a reproductive age.

27 June 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
XWXi Wang
Xi Wang
BZBaoli Zhu
Baoli Zhu
QLQiuying Liu
Qiuying Liu
XZXi Zeng
Xi Zeng
YLYan Liu
Yan Liu
BZBaoli Zhu
Baoli Zhu
Probiotics demonstrate the ability to maintain intestinal homeostasis and promote gut health. However, their effects on gut microbiota in adults over 60 years old with chronic metabolic disease (CMD) or cardio-cerebrovascular disease (CCD) remain poorly understood. This study analyzed 1586 stool samples from 1377 adults (CMD, CCD, and healthy controls) using 16S rRNA sequencing. Cohort 1 (n = 1168) was used for cross-sectional analysis, while cohort 2 (n = 209) underwent longitudinal assessment over approximately 13 months. The results demonstrated that probiotics promoted significant gut microbiota alterations across both cohorts. Probiotic supplementation significantly increased lactobacilli in the CMD, CCD, and H groups. In both cohorts, probiotic supplementation enhanced Butyricicoccus, Clostridium sensu stricto 1, and Coprococcus in H groups, enhanced Anaerostipes and Fusicatenibacter in CMD groups, and reduced Haemophilus and Lachnospira in CCD groups. Notably, long-term supplementation not only elevated Dorea, Eubacterium hallii group, and Blautia in all groups but also suppressed Klebsiella and Bilophila in the CMD and CCD groups. Enterotype analysis revealed that probiotics increased the proportion of enterotype 1 and transition probabilities from enterotype 2 to 1 in the CMD and CCD groups, demonstrating that CCD/CMD gut microbiota exhibited greater responsiveness to probiotic modulation. Overall, this study suggests probiotics’ role in modulating adult gut microbiota and their potential benefits in chronic metabolic and cardio-cerebrovascular diseases.